CD34-based enrichment of genetically engineered human T cells for clinical use results in dramatically enhanced tumor targeting.
about
Linear and branched glyco-lipopeptide vaccines follow distinct cross-presentation pathways and generate different magnitudes of antitumor immunityHCV T Cell Receptor Chain Modifications to Enhance Expression, Pairing, and Antigen Recognition in T Cells for Adoptive Transfer.Stem cell-derived tissue-associated regulatory T cells ameliorate the development of autoimmunity.Effector CD8+ T-cell Engraftment and Antitumor Immunity in Lymphodepleted Hosts Is IL7Rα Dependent.Interleukin-12 enhances the function and anti-tumor activity in murine and human CD8(+) T cells.IL-12 conditioning improves retrovirally mediated transduction efficiency of CD8+ T cellsTCR gene-modified T cells can efficiently treat established hepatitis C-associated hepatocellular carcinoma tumorsBlocking TCR restimulation induced necroptosis in adoptively transferred T cells improves tumor control.Adoptive immunotherapy of cancer: Gene transfer of T cell specificity.The split nature of tumor-infiltrating leukocytes: Implications for cancer surveillance and immunotherapy.Bioinformatics advances for clinical biomarker development.Melanoma Immunotherapy in Mice Using Genetically Engineered Pluripotent Stem Cells.Hepatitis C virus-cross-reactive TCR gene-modified T cells: a model for immunotherapy against diseases with genomic instability.Critical biological parameters modulate affinity as a determinant of function in T-cell receptor gene-modified T-cells.Efficacy of Adoptive T-cell Therapy Is Improved by Treatment with the Antioxidant N-Acetyl Cysteine, Which Limits Activation-Induced T-cell Death.Clinical and immunologic evaluation of three metastatic melanoma patients treated with autologous melanoma-reactive TCR-transduced T cells.N-acetyl cysteine protects anti-melanoma cytotoxic T cells from exhaustion induced by rapid expansion via the downmodulation of Foxo1 in an Akt-dependent manner.Altered Peptide Ligands Impact the Diversity of Polyfunctional Phenotypes in T Cell Receptor Gene-Modified T Cells.
P2860
Q33614657-BB64ACCC-6272-41A2-8F72-EF990B7265B8Q33735871-C4CF2AF1-0433-4378-B491-91CEC03E38E7Q36548686-74830F16-C262-4FEA-8133-8F6A82E9D6D9Q36616920-AEE8013C-8B02-4ED3-A094-5EDD19FC1597Q36721440-12B57500-7BC4-4B91-8FBB-71F220EC4FEFQ36727794-0645D50C-07EE-4344-8232-7C9BB251A484Q36951685-D0B0984E-7206-4C52-A1D5-FD345BA3F3FCQ37688373-6F3A30DC-FACF-4550-BE8E-D25E2431613EQ37980749-5EDF4EB3-B0D5-4BA8-B1F8-9B18D721F4F9Q38039112-8A4431A6-398C-45DA-BB20-2FA71426C6A4Q38088378-2B014B7F-3F15-44CE-B61E-04A956372D2AQ38802594-901C2057-1859-4DC4-B2C9-1E85E837E00CQ39964234-ECDEDA01-19DF-4287-B5A1-142E681DBAE0Q40151758-82FCA886-C901-4CE4-85FA-C6FAD1B534D8Q42381105-8D239F51-258D-44B3-AA5D-782BD27FEBE2Q47625086-ECA0070C-C505-40B9-8813-94428B1D099BQ48112031-32062867-AF0D-4B44-8A45-DC465E1AA000Q52367953-4536D0B5-3F90-4ED0-81DD-8DB20E546C52
P2860
CD34-based enrichment of genetically engineered human T cells for clinical use results in dramatically enhanced tumor targeting.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
CD34-based enrichment of genet ...... ally enhanced tumor targeting.
@en
CD34-based enrichment of genet ...... ally enhanced tumor targeting.
@nl
type
label
CD34-based enrichment of genet ...... ally enhanced tumor targeting.
@en
CD34-based enrichment of genet ...... ally enhanced tumor targeting.
@nl
prefLabel
CD34-based enrichment of genet ...... ally enhanced tumor targeting.
@en
CD34-based enrichment of genet ...... ally enhanced tumor targeting.
@nl
P2093
P2860
P1476
CD34-based enrichment of genet ...... cally enhanced tumor targeting
@en
P2093
Aaron Lesher
Anquanette Temple
Glenda G Callender
James McCracken
Jeffrey J Roszkowski
José Guevara-Patiño
Michael I Nishimura
Rimas Orentas
Telma Martins da Palma
Timothy Clay
P2860
P2888
P304
P356
10.1007/S00262-009-0810-8
P577
2010-01-06T00:00:00Z
P5875
P6179
1028215581